Advisory Committee on Health Research. 2002. Genomics and world health. Geneva, Switzerland: World Health Organization.
American Cancer Society. 2017. Breast Cancer Facts & Figures 2017–2018. Atlanta, GA: American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf (accessed September 28, 2018).
Butrick, M., S. Kelly, B. N. Peshkin, G. Luta, R. Nusbaum, G. W. Hooker, K. Graves, L. Feeley, C. Isaacs, H. B. Valdimarsdottir, L. Jandorf, T. DeMarco, M. Wood, W. McKinnon, J. Garber, S. R. McCormick, and M. D. Schwartz. 2015. Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genetic Medicine 17(6):467–475.
Carethers, J. M., and E. M. Stoffel. 2015. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. World Journal of Gastroenterology 21(31):9253–9261.
CDC (Centers for Disease Control and Prevention). 2016. Preventive services covered without cost sharing. https://www.cdc.gov/nchhstp/preventionthroughhealthcare/healthdepartments/services.htm (accessed August 29, 2018).
Cheng, J. K. Y., C. Guerra, R. J. Pasick, D. Schillinger, J. Luce, and G. Joseph. 2018. Cancer genetic counseling communication with low-income Chinese immigrants. Journal of Community Genetics 9(3):263–276.
Childers, K. K., M. Maggard-Gibbons, J. Macinko, and C. P. Childers. 2018. National distribution of cancer genetic testing in the United States: Evidence for a gender disparity in hereditary breast and ovarian cancer. JAMA Oncology 4(6):876–879.
Chun, D. S., B. Berse, V. L. Venne, S. L. DuVall, K. K. Filipski, M. J. Kelley, L. J. Meyer, M. S. Icardi, and J. A. Lynch. 2017. BRCA testing within the Department of Veterans Affairs: Concordance with clinical practice guidelines. Familial Cancer 16(1):41–49.
Deverka, P., D. A. Messner, R. McCormack, G. H. Lyman, M. Piper, L. Bradley, D. Parkinson, D. Nelson, H. L. McLeod, M. L. Smith, L. Jacques, T. Dutta, and S. R. Tunis. 2016. Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology. Genetic Medicine 18(8):780–787.
Dougherty, M. J., C. Pleasants, L. Solow, A. Wong, H. Zhang, and E. Stone. 2011. A comprehensive analysis of high school genetics standards: Are states keeping pace with modern genetics? CBE—Life Sciences Education 10(3):318–327.
FDA (U.S. Food and Drug Administration). 2018. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. March 6. www.fda.gov/newsevents/newsroom/pressannouncements/ucm599560.htm (accessed August 20, 2018).
Fontaine, S. A., U. K. Henschke, L. D. Leffall, Jr., C. H. Mason, A. W. Reinhold, R. Schneider, and J. E. White. 1972. Comparison of the cancer deaths in the black and white U.S.A. population from 1949 to 1967. Medical Annals of the District of Columbia 41(5):293–298.
Francke, U., C. Dijamco, A. K. Kiefer, N. Eriksson, B. Moiseff, J. Y. Tung, and J. L. Mountain. 2013. Dealing with the unexpected: Consumer responses to direct-access BRCA mutation testing. PeerJ 1:e8.
Friedman, S. 2018. Solving for y: Reaching men about genetic testing for hereditary breast, ovarian, pancreatic, prostate and related cancers (HBOC). FORCE Blog, June 17. http://www.facingourrisk.org/get-involved/HBOC-community/BRCA-HBOC-blogs/FORCE/uncategorized/solving-for-y-genetic-testing-in-men (accessed September 16, 2018).
Funk, C., and S. K. Goo. 2015. A look at what the public knows and does not know about science. Washington, DC: Pew Research Center.
Green, R. C., K. A. B. Goddard, G. P. Jarvik, L. M. Amendola, P. S. Appelbaum, J. S. Berg, B. A. Bernhardt, L. G. Biesecker, S. Biswas, C. L. Blout, K. M. Bowling, K. B. Brothers, W. Burke, C. F. Caga-Anan, A. M. Chinnaiyan, W. K. Chung, E. W. Clayton, G. M. Cooper, K. East, J. P. Evans, S. M. Fullerton, L. A. Garraway, J. R. Garrett, S. W. Gray, G. E. Henderson, L. A. Hindorff, I. A. Holm, M. H. Lewis, C. M. Hutter, P. A. Janne, S. Joffe, D. Kaufman, B. M. Knoppers, B. A. Koenig, I. D. Krantz, T. A. Manolio, L. McCullough, J. McEwen, A. McGuire, D. Muzny, R. M. Myers, D. A. Nickerson, J. Ou, D. W. Parsons, G. M. Petersen, S. E. Plon, H. L. Rehm, J. S. Roberts, D. Robinson, J. S. Salama, S. Scollon, R. R. Sharp, B. Shirts, N. B. Spinner, H. K. Tabor, P. Tarczy-Hornoch, D. L. Veenstra, N. Wagle, K. Weck, B. S. Wilfond, K. Wilhelmsen, S. M. Wolf, J. Wynn, and J. H. Yu. 2016. Clinical sequencing exploratory research consortium: Accelerating evidence-based practice of genomic medicine. American Journal of Human Genetics 98(6):1051–1066.
Hauser, D., A. O. Obeng, K. Fei, M. A. Ramos, and C. R. Horowitz. 2018. Views of primary care providers on testing patients for genetic risks for common chronic diseases. Health Affairs (Millwood) 37(5):793–800.
Howard, J., B. F. Hankey, R. S. Greenberg, D. F. Austin, P. Correa, V. W. Chen, and S. Durako. 1992. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer 69(9):2349–2360.
IOM (Institute of Medicine). 2002. Unequal treatment: Confronting racial and ethnic disparities in health care. Washington, DC: The National Academies Press.
IOM. 2015. Improving genetics education in graduate and continuing health professional education: Workshop summary. Washington, DC: The National Academies Press.
Jacobs, A. S., M. D. Schwartz, H. Valdimarsdottir, R. H. Nusbaum, G. W. Hooker, T. A. DeMarco, J. E. Heinzmann, W. McKinnon, S. R. McCormick, C. Davis, A. D. Forman, A. P. Lebensohn, E. Dalton, D. M. Tully, K. D. Graves, M. Similuk, S. Kelly, and B. N. Peshkin. 2016. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer. Familial Cancer 15(4):529–539.
Joseph, G., C. Kaplan, J. Luce, R. Lee, S. Stewart, C. Guerra, and R. Pasick. 2012. Efficient identification and referral of low-income women at high risk for hereditary breast cancer: A practice-based approach. Public Health Genomics 15(3–4):172–180.
Joseph, G., R. J. Pasick, D. Schillinger, J. Luce, C. Guerra, and J. K. Y. Cheng. 2017a. Erratum to: Information mismatch: Cancer risk counseling with diverse underserved patients. Journal of Genetic Counseling 26(5):1105.
Joseph, G., R. J. Pasick, D. Schillinger, J. Luce, C. Guerra, and J. K. Y. Cheng. 2017b. Information mismatch: Cancer risk counseling with diverse underserved patients. Journal of Genetic Counseling 26(5):1090–1104.
Kamara, D., J. Weil, J. Youngblom, C. Guerra, and G. Joseph. 2018. Cancer counseling of low-income limited english proficient latina women using medical interpreters: Implications for shared decision-making. Journal of Genetic Counseling 27(1):155–168.
Lennerz, J. K., H. M. McLaughlin, J. M. Baron, D. Rasmussen, M. Sumbada Shin, N. Berners-Lee, J. Miller Batten, K. J. Swoboda, M. K. Gala, H. S. Winter, J. D. Schmahmann, D. A. Sweetser, M. Boswell, M. Pacula, A. Stenzinger, L. P. Le, W. Hynes, H. L. Rehm, A. Klibanski, S. W. Black-Schaffer, J. A. Golden, D. N. Louis, S. T. Weiss, and A. J. Iafrate. 2016. Health care infrastructure for financially sustainable clinical genomics. Journal of Molecular Diagnostics 18(5):697–706.
Luizon, M. R., W. L. Eckalbar, Y. Wang, S. L. Jones, R. P. Smith, M. Laurance, L. Lin, P. J. Gallins, A. S. Etheridge, F. Wright, Y. Zhou, C. Molony, F. Innocenti, S. W. Yee, K. M. Giacomini, and N. Ahituv. 2016. Genomic characterization of metformin hepatic response. PLOS Genetics 12(11):e1006449.
Lynch, H. T., C. L. Snyder, T. G. Shaw, C. D. Heinen, and M. P. Hitchins. 2015. Milestones of Lynch syndrome: 1895–2015. Nature Reviews Cancer 15(3):181–194.
McCarthy, A. M., M. Bristol, S. M. Domchek, P. W. Groeneveld, Y. Kim, U. N. Motanya, J. A. Shea, and K. Armstrong. 2016. Health care segregation, physician recommendation, and racial disparities in BRCA1/2 testing among women with breast cancer. Journal of Clinical Oncology 34(22):2610–2618.
McGrath, R. J., D. J. Laflamme, A. P. Schwartz, M. Stransky, and J. B. Moeschler. 2009. Access to genetic counseling for children with autism, Down syndrome, and intellectual disabilities. Pediatrics 124(Suppl 4):S443–S449.
Mikat-Stevens, N. A., I. A. Larson, and B. A. Tarini. 2015. Primary-care providers’ perceived barriers to integration of genetics services: A systematic review of the literature. Genetic Medicine 17(3):169–176.
NASEM (National Academies of Sciences, Engineering, and Medicine). 2018. Making medicines affordable: A national imperative. Washington, DC: The National Academies Press.
NCCN (National Comprehensive Cancer Network). 2018. Genetic/familial high-risk assessment: Breast and ovarian (Version 2.2018). www.nccn.org/professionals/physician_gls/pdf/bone.pdf (accessed August 20, 2018).
NHGRI (National Human Genome Research Institute). 2018. What is genomic medicine?https://www.genome.gov/27552451/what-is-genomic-medicine/#al-1 (accessed August 16, 2018).
Pasick, R. J., G. Joseph, S. Stewart, C. Kaplan, R. Lee, J. Luce, S. Davis, T. Marquez, T. Nguyen, and C. Guerra. 2016. Effective referral of low-income women at risk for hereditary breast and ovarian cancer to genetic counseling: A randomized delayed intervention control trial. American Journal of Public Health 106(10):1842–1848.
Peshkin, B. N., S. Kelly, R. H. Nusbaum, M. Similuk, T. A. DeMarco, G. W. Hooker, H. B. Valdimarsdottir, A. D. Forman, J. R. Joines, C. Davis, S. R. McCormick, W. McKinnon, K. D. Graves, C. Isaacs, J. Garber, M. Wood, L. Jandorf, and M. D. Schwartz. 2016. Patient perceptions of telephone vs. in-person BRCA1/BRCA2 genetic counseling. Journal of Genetic Counseling 25(3):472–482.
Rahimzadeh, V., and G. Bartlett. 2014. Genetics and primary care: Where are we headed? Journal of Translational Medicine 12:238.
Rahman, A., R. Chow, P. Davis, R. Depew, C. Esiobu, P. Hong, A. Ifeadike, B. Lim, C. Marts, R. Rastogi, J. M. Singh, M. Xie, and C. Zhong. 2013. Preparing for personalized medicine in Massachusetts: Enhancing genetics education for patients and health professionals. Harvard University Institute of Politics. http://www.iop.harvard.edu/sites/default/files_new/research-policy-papers/Preparing_for_Personalized_Medicine_Massachusetts.pdf (accessed November 2, 2018).
Ram, N., C. J. Guerrini, and A. L. McGuire. 2018. Genealogy databases and the future of criminal investigation. Science 360(6393):1078–1079.
Reynolds, T. 1997. Panel grapples with the legacy of “race medicine” in research. Journal of the National Cancer Institute 89(11):758–761.
Rezende, L. 2016. How patients decide to participate in clinical trials: Results of the Project IMPACT survey.http://www.facingourrisk.org/research-clinical-trials/research-findings/clinical-trial-participation.php (accessed July 23, 2018).
Schwartz, M. D., H. B. Valdimarsdottir, B. N. Peshkin, J. Mandelblatt, R. Nusbaum, A. T. Huang, Y. Chang, K. Graves, C. Isaacs, M. Wood, W. McKinnon, J. Garber, S. McCormick, A. Y. Kinney, G. Luta, S. Kelleher, K. G. Leventhal, P. Vegella, A. Tong, and L. King. 2014. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. Journal of Clinical Oncology 32(7):618–626.
Schwartz, M. D., B. N. Peshkin, C. Isaacs, S. Willey, H. B. Valdimarsdottir, R. Nusbaum, G. Hooker, S. O’Neill, L. Jandorf, S. P. Kelly, J. Heinzmann, A. Zidell, and K. Khoury. 2018. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients. Breast Cancer Research and Treatment 170(3):517–524.
Sherman, B. W., T. B. Gibson, W. D. Lynch, and C. Addy. 2017. Health care use and spending patterns vary by wage level in employer-sponsored plans. Health Affairs (Millwood) 36(2):250–257.
Shipman, S. A., J. Lan, C. H. Chang, and D. C. Goodman. 2011. Geographic maldistribution of primary care for children. Pediatrics 127(1):19–27.
Singh, G. K., and A. Jemal. 2017. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: Over six decades of changing patterns and widening inequalities. Journal of Environmental and Public Health 2017:2819372.
Sparano, J. A., R. J. Gray, D. F. Makower, K. I. Pritchard, K. S. Albain, D. F. Hayes, C. E. Geyer, Jr., E. C. Dees, M. P. Goetz, J. A. Olson, Jr., T. Lively, S. S. Badve, T. J. Saphner, L. I. Wagner, T. J. Whelan, M. J. Ellis, S. Paik, W. C. Wood, P. M. Ravdin, M. M. Keane, H. L. Gomez Moreno, P. S. Reddy, T. F. Goggins, I. A. Mayer, A. M. Brufsky, D. L. Toppmeyer, V. G. Kaklamani, J. L. Berenberg, J. Abrams, and G. W. Sledge Jr. 2018. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. New England Journal of Medicine 379(2):111–121.
Spellberg, B., J. G. Bartlett, and D. N. Gilbert. 2016. How to pitch an antibiotic stewardship program to the hospital C-suite. Open Forum Infectious Diseases 3(4):ofw210.
Stewart, S. L., C. P. Kaplan, R. Lee, G. Joseph, L. Karliner, J. Livaudais-Toman, and R. J. Pasick. 2016. Validation of an efficient screening tool to identify low-income women at high risk for hereditary breast cancer. Public Health Genomics 19(6):342–351.
Taylor, J. Y. 2009a. Risks for hypertension among undiagnosed African American mothers and daughters. Journal of Pediatric Health Care 23(6):378–387.
Taylor, J. Y. 2009b. Recruitment of three generations of African American women into genetics research. Journal of Transcultural Nursing 20(2):219–226.
Taylor, J. Y., D. Sampson, A. D. Taylor, D. Caldwell, and Y. V. Sun. 2013. Genetic and BMI risks for predicting blood pressure in three generations of West African Dogon women. Biological Research for Nursing 15(1):105–111.